Source: Annual Congress 2007 - Clinical aspects of COPD II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Grebneva, G. Ignatova, N. Sokolova, I. Drozdov (Chelyabinsk, Russian Federation). Death rate of COPD patients and combination with type 2 diabetes. Eur Respir J 2007; 30: Suppl. 51, 610

Member's Comments

No comment yet.

Related content which might interest you: Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Impact of diabetes in patients with COPD Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2 Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Lung function in children with juvenile diabetes type 1 Source: Eur Respir J 2002; 20: Suppl. 38, 139s Year: 2002 Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2) Source: Annual Congress 2010 - COPD: management Year: 2010 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Adverse events in the treatment of patients with pulmonary tuberculosis combined with diabetes mellitus and without it. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Insulin therapy increases airway responsiveness in type 2 diabetes patients Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011 Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021